Article
Evaluation of clinical and genetic indicators for the early response to intravitreal ranibizumab in exudative age-related macular degeneration.
Pharmacogenomics - 1 Apr 2014
Matsumiya Wataru, Honda Shigeru, Yanagisawa Suiho, Miki Akiko, Nagai Takayuki, Tsukahara Yasutomo
Abstract excerpt
AIM: This study was conducted to evaluate the possible clinical and genetic indicators for an early response to intravitreal ranibizumab (IVR) in exudative age-related macular degeneration (AMD). PATIENTS & METHODS: The records of 120 eyes from 120 Japanese patients with treatment-naive exudative AMD were retrospectively reviewed. Three consecutive IVR treatments were performed every month. Achievement of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
